A plant-derived acid from anise and fennel with a long, safe history as a fragrance, flavoring, and gentle preservative. Laboratory work suggests it reduces skin pigment formation, calms inflammation, and neutralizes damaging molecules, but no human trials exist. Best seen today as a safe cosmetic ingredient with modest skin activity and unproven internal-health value. (Full Review)

Protocol

Topical Concentration

0.1–1.0%

In acidic skincare formulations

Route

Topical

Preservative and secondary skin-brightening active; oral use investigational

Timing

Evening

Acidic actives often applied at night to limit sun sensitivity

Time to effect

Skin Brightening

8–12 weeks

Visible pigmentation change with consistent use

Metabolic Effect

No human data

No human time-course exists

Skin Tolerance

1–2 weeks

Early window to reassess for irritation

Benefits

Low: Antimicrobial and preservative activity; tyrosinase inhibition and skin brightening; antioxidant free-radical scavenging

Speculative: Blood glucose regulation; anti-inflammatory effects; anti-anxiety and neuroprotective potential; anti-tumor activity

Contraindications

Known allergy to p-anisic acid, benzoates, or fragrance components

Pregnancy or breastfeeding (oral use)

Children (oral use)

Key Interactions

Antidiabetic drugs (sulfonylureas, insulin)

Glucose-lowering supplements (berberine, cinnamon extract, chromium)

Other low-pH topical actives (high-strength alpha-hydroxy acids)

Risk & Side Effects

Low: Skin irritation at high concentrations; allergic contact sensitization

Speculative: Unknown effects of chronic oral supplementation; benzoate/salicylate-related sensitivity

Monitoring

Marker	Target	Why
Fasting glucose	75–90 mg/dL	Tracks the theoretical glucose-lowering effect
HbA1c	< 5.4%	Average blood sugar over ~3 months
ALT / AST	< 25 U/L	Screens liver, the main site of clearance
eGFR	> 90 mL/min/1.73m²	Confirms kidney clearance capacity
hs-CRP	< 1.0 mg/L	Contextualizes the proposed anti-inflammatory effect

Cadence: Systemic use: baseline, 4–12 weeks, then every 6–12 months. Topical: reassess skin tolerance at 1–2 weeks, pigmentation at 8–12 weeks.

Qualitative Assessment

Skin tone evenness and reduction in visible dark spots or hyperpigmentation
Overall skin comfort and absence of irritation, redness, or stinging
General energy and well-being (non-specific)

p-Anisic Acid for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment